The company said it continues to have near normal operations in the quarter complying with all Covid-19 protocols.
Divis Laboratories is the leading manufacturer of APIs (Active Pharmaceuticals Ingredients), intermediates and registered starting materials offering high quality products with the highest level of compliance and integrity to over 95 countries.
Shares of Divi's Laboratories ended 1.17% higher at Rs 5,205.05 in the special one-hour Muhurat trading session on Thursday, 4 November 2021.